ASML vs. UNH: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at ASML and UNH, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Overview
ASML’s market capitalization stands at 312.40 billion USD, while UNH’s is 279.90 billion USD, indicating their market valuations are broadly comparable.
ASML’s beta of 1.22 points to significantly higher volatility compared to UNH (beta: 0.45), suggesting ASML has greater potential for both gains and losses relative to market movements.
ASML trades as an American Depositary Receipt (ADR), offering U.S. investors a convenient way to access its foreign-listed shares. In contrast, UNH is a standard domestic listing.
| Symbol | ASML | UNH |
|---|---|---|
| Company Name | ASML Holding N.V. | UnitedHealth Group Incorporated |
| Country | NL | US |
| Sector | Technology | Healthcare |
| Industry | Semiconductors | Medical - Healthcare Plans |
| CEO | Christophe D. Fouquet | Stephen J. Hemsley |
| Price | 794.5 USD | 308.55 USD |
| Market Cap | 312.40 billion USD | 279.90 billion USD |
| Beta | 1.22 | 0.45 |
| Exchange | NASDAQ | NYSE |
| IPO Date | March 15, 1995 | October 17, 1984 |
| ADR | Yes | No |
Historical Performance
This chart compares the performance of ASML and UNH by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period.
Data is adjusted for dividends and splits.
Profitability
Return on Equity
ASML
52.08%
Semiconductors Industry
- Max
- 41.84%
- Q3
- 15.81%
- Median
- 6.31%
- Q1
- -5.54%
- Min
- -30.12%
ASML’s Return on Equity of 52.08% is exceptionally high, placing it well beyond the typical range for the Semiconductors industry. This demonstrates a superior ability to generate profit from shareholder investments, though it could also be inflated by high financial leverage.
UNH
24.09%
Medical - Healthcare Plans Industry
- Max
- 13.94%
- Q3
- 13.62%
- Median
- 11.42%
- Q1
- 7.74%
- Min
- 6.98%
UNH’s Return on Equity of 24.09% is exceptionally high, placing it well beyond the typical range for the Medical - Healthcare Plans industry. This demonstrates a superior ability to generate profit from shareholder investments, though it could also be inflated by high financial leverage.
Return on Invested Capital
ASML
30.91%
Semiconductors Industry
- Max
- 30.91%
- Q3
- 11.34%
- Median
- 4.08%
- Q1
- -2.17%
- Min
- -19.59%
In the upper quartile for the Semiconductors industry, ASML’s Return on Invested Capital of 30.91% signifies a highly effective use of its capital to generate profits when compared to its peers.
UNH
13.21%
Medical - Healthcare Plans Industry
- Max
- 15.50%
- Q3
- 7.12%
- Median
- 5.48%
- Q1
- -3.47%
- Min
- -15.02%
In the upper quartile for the Medical - Healthcare Plans industry, UNH’s Return on Invested Capital of 13.21% signifies a highly effective use of its capital to generate profits when compared to its peers.
Net Profit Margin
ASML
28.33%
Semiconductors Industry
- Max
- 51.69%
- Q3
- 19.67%
- Median
- 8.56%
- Q1
- -5.44%
- Min
- -38.60%
A Net Profit Margin of 28.33% places ASML in the upper quartile for the Semiconductors industry, signifying strong profitability and more effective cost management than most of its peers.
UNH
5.43%
Medical - Healthcare Plans Industry
- Max
- 3.23%
- Q3
- 2.62%
- Median
- 1.70%
- Q1
- 1.27%
- Min
- 1.22%
UNH’s Net Profit Margin of 5.43% is exceptionally high, placing it well beyond the typical range for the Medical - Healthcare Plans industry. This demonstrates outstanding operational efficiency and a strong competitive advantage in converting revenue into profit.
Operating Profit Margin
ASML
33.76%
Semiconductors Industry
- Max
- 58.03%
- Q3
- 22.12%
- Median
- 8.40%
- Q1
- -3.73%
- Min
- -36.14%
An Operating Profit Margin of 33.76% places ASML in the upper quartile for the Semiconductors industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.
UNH
8.22%
Medical - Healthcare Plans Industry
- Max
- 4.30%
- Q3
- 3.77%
- Median
- 2.61%
- Q1
- 1.60%
- Min
- -1.64%
UNH’s Operating Profit Margin of 8.22% is exceptionally high, placing it well above the typical range for the Medical - Healthcare Plans industry. This demonstrates outstanding efficiency in managing its core operations, which can be a result of strong pricing power or superior cost control.
Profitability at a Glance
| Symbol | ASML | UNH |
|---|---|---|
| Return on Equity (TTM) | 52.08% | 24.09% |
| Return on Assets (TTM) | 19.14% | 7.14% |
| Return on Invested Capital (TTM) | 30.91% | 13.21% |
| Net Profit Margin (TTM) | 28.33% | 5.43% |
| Operating Profit Margin (TTM) | 33.76% | 8.22% |
| Gross Profit Margin (TTM) | 52.01% | 21.48% |
Financial Strength
Current Ratio
ASML
1.52
Semiconductors Industry
- Max
- 9.10
- Q3
- 5.23
- Median
- 3.09
- Q1
- 2.49
- Min
- 1.02
ASML’s Current Ratio of 1.52 falls into the lower quartile for the Semiconductors industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.
UNH
0.85
Medical - Healthcare Plans Industry
- Max
- 1.91
- Q3
- 1.63
- Median
- 1.43
- Q1
- 0.85
- Min
- 0.78
UNH’s Current Ratio of 0.85 aligns with the median group of the Medical - Healthcare Plans industry, indicating that its short-term liquidity is in line with its sector peers.
Debt-to-Equity Ratio
ASML
0.21
Semiconductors Industry
- Max
- 0.97
- Q3
- 0.46
- Median
- 0.21
- Q1
- 0.05
- Min
- 0.00
ASML’s Debt-to-Equity Ratio of 0.21 is typical for the Semiconductors industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
UNH
0.86
Medical - Healthcare Plans Industry
- Max
- 1.06
- Q3
- 0.86
- Median
- 0.75
- Q1
- 0.66
- Min
- 0.66
UNH’s Debt-to-Equity Ratio of 0.86 is typical for the Medical - Healthcare Plans industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
Interest Coverage Ratio
ASML
--
Semiconductors Industry
- Max
- 36.25
- Q3
- 29.12
- Median
- 7.01
- Q1
- -1.22
- Min
- -18.18
Interest Coverage Ratio data for ASML is currently unavailable.
UNH
16.30
Medical - Healthcare Plans Industry
- Max
- 6.23
- Q3
- 6.23
- Median
- 5.19
- Q1
- 4.64
- Min
- 3.18
With an Interest Coverage Ratio of 16.30, UNH demonstrates a superior capacity to service its debt, placing it well above the typical range for the Medical - Healthcare Plans industry. This stems from either robust earnings or a conservative debt load.
Financial Strength at a Glance
| Symbol | ASML | UNH |
|---|---|---|
| Current Ratio (TTM) | 1.52 | 0.85 |
| Quick Ratio (TTM) | 0.91 | 0.85 |
| Debt-to-Equity Ratio (TTM) | 0.21 | 0.86 |
| Debt-to-Asset Ratio (TTM) | 0.08 | 0.26 |
| Net Debt-to-EBITDA Ratio (TTM) | -0.47 | 1.57 |
| Interest Coverage Ratio (TTM) | -- | 16.30 |
Growth
The following charts compare key year-over-year (YoY) growth metrics for ASML and UNH. These metrics are based on the companies’ annual financial reports.
Revenue Growth
Earnings Per Share (EPS) Growth
Free Cash Flow Growth
Dividend
Dividend Yield
ASML
0.85%
Semiconductors Industry
- Max
- 6.48%
- Q3
- 0.93%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
ASML’s Dividend Yield of 0.85% is consistent with its peers in the Semiconductors industry, providing a dividend return that is standard for its sector.
UNH
2.76%
Medical - Healthcare Plans Industry
- Max
- 3.88%
- Q3
- 1.78%
- Median
- 0.73%
- Q1
- 0.00%
- Min
- 0.00%
With a Dividend Yield of 2.76%, UNH offers a more attractive income stream than most of its peers in the Medical - Healthcare Plans industry, signaling a strong commitment to shareholder returns.
Dividend Payout Ratio
ASML
28.49%
Semiconductors Industry
- Max
- 204.29%
- Q3
- 31.85%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
ASML’s Dividend Payout Ratio of 28.49% is within the typical range for the Semiconductors industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
UNH
34.90%
Medical - Healthcare Plans Industry
- Max
- 63.88%
- Q3
- 29.91%
- Median
- 12.57%
- Q1
- 0.00%
- Min
- 0.00%
UNH’s Dividend Payout Ratio of 34.90% is in the upper quartile for the Medical - Healthcare Plans industry. This indicates a strong commitment to shareholder returns but also suggests that a smaller portion of earnings is retained for reinvestment compared to many peers.
Dividend at a Glance
| Symbol | ASML | UNH |
|---|---|---|
| Dividend Yield (TTM) | 0.85% | 2.76% |
| Dividend Payout Ratio (TTM) | 28.49% | 34.90% |
Valuation
Price-to-Earnings Ratio
ASML
29.72
Semiconductors Industry
- Max
- 86.15
- Q3
- 47.38
- Median
- 27.87
- Q1
- 18.89
- Min
- 4.73
ASML’s P/E Ratio of 29.72 is within the middle range for the Semiconductors industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
UNH
12.81
Medical - Healthcare Plans Industry
- Max
- 18.17
- Q3
- 17.32
- Median
- 15.48
- Q1
- 13.55
- Min
- 12.84
UNH’s P/E Ratio of 12.81 is below the typical range for the Medical - Healthcare Plans industry. This may indicate that the stock is potentially undervalued, or it could reflect market concerns about the company’s future prospects.
Forward P/E to Growth Ratio
ASML
1.90
Semiconductors Industry
- Max
- 4.73
- Q3
- 2.80
- Median
- 1.11
- Q1
- 0.68
- Min
- 0.01
The Forward PEG Ratio is often not a primary valuation metric in the Semiconductors industry.
UNH
0.78
Medical - Healthcare Plans Industry
- Max
- 1.41
- Q3
- 1.09
- Median
- 0.85
- Q1
- 0.79
- Min
- 0.60
In the lower quartile for the Medical - Healthcare Plans industry, UNH’s Forward PEG Ratio of 0.78 is a positive indicator. It suggests that the stock may be attractively valued relative to its expected earnings growth.
Price-to-Sales Ratio
ASML
8.44
Semiconductors Industry
- Max
- 21.96
- Q3
- 10.21
- Median
- 4.45
- Q1
- 2.32
- Min
- 0.48
ASML’s P/S Ratio of 8.44 aligns with the market consensus for the Semiconductors industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
UNH
0.69
Medical - Healthcare Plans Industry
- Max
- 0.94
- Q3
- 0.64
- Median
- 0.43
- Q1
- 0.27
- Min
- 0.16
UNH’s P/S Ratio of 0.69 is in the upper echelon for the Medical - Healthcare Plans industry. This means the company is valued richly on its revenue stream compared to its peers, suggesting the stock is priced for a high level of future performance.
Price-to-Book Ratio
ASML
14.78
Semiconductors Industry
- Max
- 13.12
- Q3
- 6.49
- Median
- 3.31
- Q1
- 1.74
- Min
- 0.23
At 14.78, ASML’s P/B Ratio is at an extreme premium to the Semiconductors industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.
UNH
2.98
Medical - Healthcare Plans Industry
- Max
- 4.08
- Q3
- 3.83
- Median
- 2.63
- Q1
- 1.74
- Min
- 0.96
UNH’s P/B Ratio of 2.98 is within the conventional range for the Medical - Healthcare Plans industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
Valuation at a Glance
| Symbol | ASML | UNH |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 29.72 | 12.81 |
| Forward PEG Ratio (TTM) | 1.90 | 0.78 |
| Price-to-Sales Ratio (P/S, TTM) | 8.44 | 0.69 |
| Price-to-Book Ratio (P/B, TTM) | 14.78 | 2.98 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 27.93 | 11.26 |
| EV-to-EBITDA (TTM) | 22.09 | 10.28 |
| EV-to-Sales (TTM) | 8.27 | 0.81 |